v3.8.0.1

Counterparty Risk | 9 Months Ended
--- | ---
Sep. 30, 2017
Risks and Uncertainties [Abstract] |
Counterparty Risk | Counterparty Risk As of September 30, 2017, investments with an aggregate value of approximately $1.16 billion were held with dealers as collateral for various reverse repurchase agreements. The investments held as collateral include securities in the amount of $13.1 million that were sold prior to period end but for which such sale had not yet settled as of September 30, 2017. At September 30, 2017 no single counterparty held more than 15% of the total amount held with dealers as collateral for various reverse repurchase agreements. In addition to the below, unencumbered investments, on a settlement date basis, of approximately $79.0 million were held in custody at the Bank of New York Mellon Corporation. The following table details the percentage of collateral amounts held by dealers who hold greater than 15% of the Company's Due from Brokers, included as of September 30, 2017:
Dealer |  | % of Total Due from Brokers
J. P. Morgan Securities LLC |  | 23%
Morgan Stanley |  | 20%
BNP Paribas Securities Corp. |  | 19%
The following table details the percentage of amounts held by dealers who hold greater than 15% of the Company's Receivable for securities sold as of September 30, 2017:
Dealer |  | % of Total Receivable for Securities Sold
Bank of America Securities |  | 29%
Morgan Stanley |  | 23%
In addition, the Company held cash and cash equivalents of $111.4 million and $123.3 million as of September 30, 2017 and December 31, 2016, respectively. The below table details the concentration of cash and cash equivalents held by each counterparty:
|  | As of
Counterparty |  | September 30, 2017 |  | December 31, 2016
Bank of New York Mellon Corporation |  | 45% |  | 27%
Goldman Sachs Financial Square Funds—Government Fund |  | 36% |  | 16%
BlackRock Liquidity Funds FedFund Portfolio |  | 18% |  | 41%
US Bank N.A. |  | 1% |  | —%
Morgan Stanley Institutional Liquidity Fund—Government Portfolio |  | —% |  | 16%

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI http://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration